Literature DB >> 34780278

Surfactant Protein A Enhances the Degradation of LPS-Induced TLR4 in Primary Alveolar Macrophages Involving Rab7, β-arrestin2, and mTORC1.

Katja Freundt1, Christian Herzmann2, Dominika Biedziak1, Claudia Scheffzük1,3, Karoline I Gaede4,5, Cordula Stamme1,3.   

Abstract

Respiratory infections by Gram-negative bacteria are a major cause of global morbidity and mortality. Alveolar macrophages (AMs) play a central role in maintaining lung immune homeostasis and host defense by sensing pathogens via pattern recognition receptors (PRR). The PRR Toll-like receptor (TLR) 4 is a key sensor of lipopolysaccharide (LPS) from Gram-negative bacteria. Pulmonary surfactant is the natural microenvironment of AMs. Surfactant protein A (SP-A), a multifunctional host defense collectin, controls LPS-induced pro-inflammatory immune responses at the organismal and cellular level via distinct mechanisms. We found that SP-A post-transcriptionally restricts LPS-induced TLR4 protein expression in primary AMs from healthy humans, rats, wild-type and SP-A-/- mice by further decreasing cycloheximide-reduced TLR4 protein translation and enhances the co-localization of TLR4 with the late endosome/lysosome. Both effects as well as the SP-A-mediated inhibition of LPS-induced TNF-α release are counteracted by pharmacological inhibition of the small GTPase Rab7. SP-A-enhanced Rab7 expression requires β-arrestin2 and, in β-arrestin2-/- AMs and after intratracheal LPS challenge of β-arrestin2-/- mice, SP-A fails to enhance TLR4/lysosome co-localization and degradation of LPS-induced TLR4. In SP-A-/- mice, TLR4 levels are increased after pulmonary LPS challenge. SP-A-induced activation of mechanistic target of rapamycin complex 1 (mTORC1) kinase requires β-arrestin2 and is critically involved in degradation of LPS-induced TLR4. The data suggest that SP-A post-translationally limits LPS-induced TLR4 expression in primary AMs by lysosomal degradation comprising Rab7, β-arrestin2, and mTORC1. This study may indicate a potential role of SP-A-based therapeutic interventions in unrestricted TLR4-driven immune responses to lower respiratory tract infections caused by Gram-negative bacteria.

Entities:  

Keywords:  LPS; TLR4; innate immunity; lung; surfactant protein A

Mesh:

Substances:

Year:  2021        PMID: 34780278      PMCID: PMC8853680          DOI: 10.1128/IAI.00250-21

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  78 in total

Review 1.  Regulation of inflammation by β-arrestins: Not just receptor tales.

Authors:  Neil J Freedman; Sudha K Shenoy
Journal:  Cell Signal       Date:  2017-02-09       Impact factor: 4.315

2.  Surfactant Proteins-A and -D Attenuate LPS-Induced Apoptosis in Primary Intestinal Epithelial Cells (IECs).

Authors:  Linlin Zhang; Qinghe Meng; Natesh Yepuri; Guirong Wang; Xiuming Xi; Robert N Cooney
Journal:  Shock       Date:  2018-01       Impact factor: 3.454

3.  Oral administration of surfactant protein-a reduces pathology in an experimental model of necrotizing enterocolitis.

Authors:  Hector D Quintanilla; Yuying Liu; Nicole Y Fatheree; Constance L Atkins; Syed S Hashmi; Joanna Floros; Francis X McCormack; Jon Marc Rhoads; Joseph L Alcorn
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-05       Impact factor: 2.839

Review 4.  The respiratory threat posed by multidrug resistant Gram-negative bacteria.

Authors:  Ana Rodrigo-Troyano; Oriol Sibila
Journal:  Respirology       Date:  2017-07-06       Impact factor: 6.424

Review 5.  Toll-like receptors in the pathogenesis of human disease.

Authors:  Donald N Cook; David S Pisetsky; David A Schwartz
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

6.  Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability.

Authors:  Huixing Wu; Alexander Kuzmenko; Sijue Wan; Lyndsay Schaffer; Alison Weiss; James H Fisher; Kwang Sik Kim; Francis X McCormack
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

7.  Rab7b Overexpression-Ameliorated Ischemic Brain Damage Following tMCAO Involves Suppression of TLR4 and NF-κB p65.

Authors:  Jinlong Qi; Yanhong Rong; Lu Wang; Junying Xu; Kun Zhao
Journal:  J Mol Neurosci       Date:  2019-03-25       Impact factor: 3.444

Review 8.  Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress.

Authors:  Shomit Sengupta; Timothy R Peterson; David M Sabatini
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

9.  Surfactant protein A reduces TLR4 and inflammatory cytokine mRNA levels in neonatal mouse ileum.

Authors:  Lidan Liu; Chaim Z Aron; Cullen M Grable; Adrian Robles; Xiangli Liu; Yuying Liu; Nicole Y Fatheree; J Marc Rhoads; Joseph L Alcorn
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

10.  The TSC-mTOR pathway regulates macrophage polarization.

Authors:  Vanessa Byles; Anthony J Covarrubias; Issam Ben-Sahra; Dudley W Lamming; David M Sabatini; Brendan D Manning; Tiffany Horng
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  1 in total

1.  Signaling Pathways That Mediate Alveolar Macrophage Activation by Surfactant Protein A and IL-4.

Authors:  Belén García-Fojeda; Carlos M Minutti; Carlos Montero-Fernández; Cordula Stamme; Cristina Casals
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.